The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glycated Haemoglobin Testing Market Research Report 2025
Synopsis
Growing adoption of a sedentary lifestyle and genetic manipulation causes type 1 or type 2 diseases. Globally, more than 400 million adults suffer from diabetes, out of which half of the incidences of diabetes remain undiagnosed.
The global Glycated Haemoglobin Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Glycated Haemoglobin Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycated Haemoglobin Testing.
Report Scope
The Glycated Haemoglobin Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycated Haemoglobin Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycated Haemoglobin Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad Laboratories
Bayer
Arkray
Chek Diagnostics
Diazyme Laboratories
X Lite-On Technology
TaiDoc Technology
Trinity Biotech
Siemens Healthcare
Ceragem Medisys
Tosoh Bioscience
DiaSys Diagnostic Systems
Erba Mannheim
Daiichi Biotech
Human Diagnostics
EKF Diagnostics
Mindray Medical
Segment by Type
Lab Based Test
Point-of-care Test
Segment by Application
Hospitals
Diagnostic Centers
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glycated Haemoglobin Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Growing adoption of a sedentary lifestyle and genetic manipulation causes type 1 or type 2 diseases. Globally, more than 400 million adults suffer from diabetes, out of which half of the incidences of diabetes remain undiagnosed.
The global Glycated Haemoglobin Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Glycated Haemoglobin Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycated Haemoglobin Testing.
Report Scope
The Glycated Haemoglobin Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycated Haemoglobin Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycated Haemoglobin Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad Laboratories
Bayer
Arkray
Chek Diagnostics
Diazyme Laboratories
X Lite-On Technology
TaiDoc Technology
Trinity Biotech
Siemens Healthcare
Ceragem Medisys
Tosoh Bioscience
DiaSys Diagnostic Systems
Erba Mannheim
Daiichi Biotech
Human Diagnostics
EKF Diagnostics
Mindray Medical
Segment by Type
Lab Based Test
Point-of-care Test
Segment by Application
Hospitals
Diagnostic Centers
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glycated Haemoglobin Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glycated Haemoglobin Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Lab Based Test
1.2.3 Point-of-care Test
1.3 Market by Application
1.3.1 Global Glycated Haemoglobin Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Glycated Haemoglobin Testing Market Perspective (2019-2030)
2.2 Glycated Haemoglobin Testing Growth Trends by Region
2.2.1 Global Glycated Haemoglobin Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Glycated Haemoglobin Testing Historic Market Size by Region (2019-2024)
2.2.3 Glycated Haemoglobin Testing Forecasted Market Size by Region (2025-2030)
2.3 Glycated Haemoglobin Testing Market Dynamics
2.3.1 Glycated Haemoglobin Testing Industry Trends
2.3.2 Glycated Haemoglobin Testing Market Drivers
2.3.3 Glycated Haemoglobin Testing Market Challenges
2.3.4 Glycated Haemoglobin Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glycated Haemoglobin Testing Players by Revenue
3.1.1 Global Top Glycated Haemoglobin Testing Players by Revenue (2019-2024)
3.1.2 Global Glycated Haemoglobin Testing Revenue Market Share by Players (2019-2024)
3.2 Global Glycated Haemoglobin Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Glycated Haemoglobin Testing Revenue
3.4 Global Glycated Haemoglobin Testing Market Concentration Ratio
3.4.1 Global Glycated Haemoglobin Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glycated Haemoglobin Testing Revenue in 2023
3.5 Glycated Haemoglobin Testing Key Players Head office and Area Served
3.6 Key Players Glycated Haemoglobin Testing Product Solution and Service
3.7 Date of Enter into Glycated Haemoglobin Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glycated Haemoglobin Testing Breakdown Data by Type
4.1 Global Glycated Haemoglobin Testing Historic Market Size by Type (2019-2024)
4.2 Global Glycated Haemoglobin Testing Forecasted Market Size by Type (2025-2030)
5 Glycated Haemoglobin Testing Breakdown Data by Application
5.1 Global Glycated Haemoglobin Testing Historic Market Size by Application (2019-2024)
5.2 Global Glycated Haemoglobin Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Glycated Haemoglobin Testing Market Size (2019-2030)
6.2 North America Glycated Haemoglobin Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Glycated Haemoglobin Testing Market Size by Country (2019-2024)
6.4 North America Glycated Haemoglobin Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Glycated Haemoglobin Testing Market Size (2019-2030)
7.2 Europe Glycated Haemoglobin Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Glycated Haemoglobin Testing Market Size by Country (2019-2024)
7.4 Europe Glycated Haemoglobin Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glycated Haemoglobin Testing Market Size (2019-2030)
8.2 Asia-Pacific Glycated Haemoglobin Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Glycated Haemoglobin Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Glycated Haemoglobin Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Glycated Haemoglobin Testing Market Size (2019-2030)
9.2 Latin America Glycated Haemoglobin Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Glycated Haemoglobin Testing Market Size by Country (2019-2024)
9.4 Latin America Glycated Haemoglobin Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glycated Haemoglobin Testing Market Size (2019-2030)
10.2 Middle East & Africa Glycated Haemoglobin Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Glycated Haemoglobin Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Glycated Haemoglobin Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Detail
11.1.2 Bio-Rad Laboratories Business Overview
11.1.3 Bio-Rad Laboratories Glycated Haemoglobin Testing Introduction
11.1.4 Bio-Rad Laboratories Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.1.5 Bio-Rad Laboratories Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Glycated Haemoglobin Testing Introduction
11.2.4 Bayer Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Arkray
11.3.1 Arkray Company Detail
11.3.2 Arkray Business Overview
11.3.3 Arkray Glycated Haemoglobin Testing Introduction
11.3.4 Arkray Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.3.5 Arkray Recent Development
11.4 Chek Diagnostics
11.4.1 Chek Diagnostics Company Detail
11.4.2 Chek Diagnostics Business Overview
11.4.3 Chek Diagnostics Glycated Haemoglobin Testing Introduction
11.4.4 Chek Diagnostics Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.4.5 Chek Diagnostics Recent Development
11.5 Diazyme Laboratories
11.5.1 Diazyme Laboratories Company Detail
11.5.2 Diazyme Laboratories Business Overview
11.5.3 Diazyme Laboratories Glycated Haemoglobin Testing Introduction
11.5.4 Diazyme Laboratories Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.5.5 Diazyme Laboratories Recent Development
11.6 X Lite-On Technology
11.6.1 X Lite-On Technology Company Detail
11.6.2 X Lite-On Technology Business Overview
11.6.3 X Lite-On Technology Glycated Haemoglobin Testing Introduction
11.6.4 X Lite-On Technology Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.6.5 X Lite-On Technology Recent Development
11.7 TaiDoc Technology
11.7.1 TaiDoc Technology Company Detail
11.7.2 TaiDoc Technology Business Overview
11.7.3 TaiDoc Technology Glycated Haemoglobin Testing Introduction
11.7.4 TaiDoc Technology Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.7.5 TaiDoc Technology Recent Development
11.8 Trinity Biotech
11.8.1 Trinity Biotech Company Detail
11.8.2 Trinity Biotech Business Overview
11.8.3 Trinity Biotech Glycated Haemoglobin Testing Introduction
11.8.4 Trinity Biotech Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.8.5 Trinity Biotech Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Detail
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare Glycated Haemoglobin Testing Introduction
11.9.4 Siemens Healthcare Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.9.5 Siemens Healthcare Recent Development
11.10 Ceragem Medisys
11.10.1 Ceragem Medisys Company Detail
11.10.2 Ceragem Medisys Business Overview
11.10.3 Ceragem Medisys Glycated Haemoglobin Testing Introduction
11.10.4 Ceragem Medisys Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.10.5 Ceragem Medisys Recent Development
11.11 Tosoh Bioscience
11.11.1 Tosoh Bioscience Company Detail
11.11.2 Tosoh Bioscience Business Overview
11.11.3 Tosoh Bioscience Glycated Haemoglobin Testing Introduction
11.11.4 Tosoh Bioscience Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.11.5 Tosoh Bioscience Recent Development
11.12 DiaSys Diagnostic Systems
11.12.1 DiaSys Diagnostic Systems Company Detail
11.12.2 DiaSys Diagnostic Systems Business Overview
11.12.3 DiaSys Diagnostic Systems Glycated Haemoglobin Testing Introduction
11.12.4 DiaSys Diagnostic Systems Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.12.5 DiaSys Diagnostic Systems Recent Development
11.13 Erba Mannheim
11.13.1 Erba Mannheim Company Detail
11.13.2 Erba Mannheim Business Overview
11.13.3 Erba Mannheim Glycated Haemoglobin Testing Introduction
11.13.4 Erba Mannheim Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.13.5 Erba Mannheim Recent Development
11.14 Daiichi Biotech
11.14.1 Daiichi Biotech Company Detail
11.14.2 Daiichi Biotech Business Overview
11.14.3 Daiichi Biotech Glycated Haemoglobin Testing Introduction
11.14.4 Daiichi Biotech Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.14.5 Daiichi Biotech Recent Development
11.15 Human Diagnostics
11.15.1 Human Diagnostics Company Detail
11.15.2 Human Diagnostics Business Overview
11.15.3 Human Diagnostics Glycated Haemoglobin Testing Introduction
11.15.4 Human Diagnostics Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.15.5 Human Diagnostics Recent Development
11.16 EKF Diagnostics
11.16.1 EKF Diagnostics Company Detail
11.16.2 EKF Diagnostics Business Overview
11.16.3 EKF Diagnostics Glycated Haemoglobin Testing Introduction
11.16.4 EKF Diagnostics Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.16.5 EKF Diagnostics Recent Development
11.17 Mindray Medical
11.17.1 Mindray Medical Company Detail
11.17.2 Mindray Medical Business Overview
11.17.3 Mindray Medical Glycated Haemoglobin Testing Introduction
11.17.4 Mindray Medical Revenue in Glycated Haemoglobin Testing Business (2019-2024)
11.17.5 Mindray Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
